<DOC>
	<DOC>NCT02298868</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of the medication Baclofen for treatment of muscle cramps in patients with cirrhosis.</brief_summary>
	<brief_title>Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Muscle Cramp</mesh_term>
	<mesh_term>Spasm</mesh_term>
	<criteria>Cirrhosis Presence of muscle cramps on a regular basis Allergy or hypersensitivity to Baclofen Active or untreated Portosystemic encephalopathy Active alcohol or substance abuse Age less than 18 Pregnancy Concomitant use of narcotic pain medication, other muscle relaxer, or other antispastic agent Concomitant use of Tricyclic Antidepressant due to drug interaction History of chronic kidney disease defined by GFR &lt; 30 (using MDRD equation) Subject is institutionalized or a prisoner Inability or unwillingness to give informed consent Expected lifespan less than 3 months Severe or poorly controlled coexisting medical conditions or other significant issues as determined by the principal investigator to hinder the ability to adhere to study protocols</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>